Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Serum concentrations of (A) N-terminal proatriopeptide (S-ANPN) and (B) N-terminal brain natriuretic peptide (S-proBNP) measured at baseline, 1 day, and 6 months after patent ductus arteriosus (PDA) closure in the whole PDA group and in patients with normal-sized left ventricle (LV) at baseline and in control subjects. *p < 0.05,  p < 0.01,  p < 0.001 as compared with control group;  p < 0.05, ¶p < 0.01 within PDA group as compared with baseline.
|
